Brooklyn Investment Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.71M Buy
24,742
+4,161
+20% +$1.48M 0.27% 52
2025
Q4
$6.78M Buy
20,581
+14,620
+245% +$4.64M 0.31% 53
2025
Q3
$1.65M Sell
5,961
-59
-1% -$17.1K 0.22% 85
2025
Q2
$1.68M Buy
6,020
+1,055
+21% +$299K 0.22% 83
2025
Q1
$1.55M Buy
4,965
+1,775
+56% +$524K 0.33% 47
2024
Q4
$831K Sell
3,190
-187
-6% -$55.5K 0.25% 75
2024
Q3
$1.09M Buy
3,377
+38
+1% +$12.4K 0.36% 57
2024
Q2
$945K Hold
3,339
0.41% 56
2024
Q1
$945K Sell
3,339
-99
-3% -$29K 0.41% 56
2023
Q4
$990K Buy
+3,438
New +$937K 0.47% 45

Other funds holding AMGN

Brooklyn Investment Group's AMGN Position: Q1 2026 in Review

Brooklyn Investment Group increased its Amgen (AMGN) stake by 20% in Q1 2026, buying an estimated $1.48M and bringing the position to 24,742 shares worth $8.71M. The position accounts for 0.27% of the portfolio, ranked #52.

Brooklyn Investment Group first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Brooklyn Investment Group held 24,742 shares of Amgen worth $8.71M as of Q1 2026.
  • Brooklyn Investment Group bought 4,161 Amgen shares in Q1 2026, an estimated $1.48M.
  • Amgen made up 0.27% of Brooklyn Investment Group's portfolio in Q1 2026, its #52 holding.
  • Brooklyn Investment Group first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.